From: Ari Belenkiy <[log in to unmask]>
Date: Sat, 19 Oct 2013 21:43:11 -0700

>> Last year researchers at one biotech firm, Amgen, found they could reproduce just six of 53 “landmark” studies in cancer research. Earlier, a group at Bayer, a drug company, managed to repeat just a quarter of 67 similarly important papers.

Does anyone know the details of these results?

Ari Belenkiy

SFU
Canada


On Sat, Oct 19, 2013 at 5:56 AM, LIBLICENSE <[log in to unmask]> wrote:
>
> From: Ann Shumelda Okerson <[log in to unmask]>
> Date: Sat, 19 Oct 2013 08:53:42 -0400
>
> Of possible interest:
>
> http://www.economist.com/news/leaders/21588069-scientific-research-has-changed-world-now-it-needs-change-itself-how-science-goes-wrong
>
> Editorial and linked article on limits of peer review,
> irreproducibility of surprisingly large proportion of published
> articles -- more fallout from the Bohannon sting?  The article notes
> that he submitted to lower-tier journals; doesn't make the open access
> correlation.